2026-03-132026-03-13Corral, P., Corral, G. and Diaz, R. (2020), Colchicine and COVID-19. The Journal of Clinical Pharmacology, 60: 978-978. https://doi.org/10.1002/jcph.16841552-4604https://dspace.ufasta.edu.ar/handle/123456789/87939In Argentina, we started COLCOVID Trial to test the effects of colchicine on moderate-/high-risk hospitalized COVID-19 patients with the aim of reducing mortality. This study is a phase 3 multicenter, controlled trial; our protocol was published in ClinicalTrial.gov on March 31, 2020.Fil: Corral, Pablo. Universidad FASTA. Facultad de Ciencias Médicas; Argentina.Fil: Corral, Gonzalo. Clínica 25 de Mayo. Hospital Interzonal General de Agudos "Dr. Oscar E. Alende". Servicio de Infectología; ArgentinaFil: Diaz, Rafael. Estudios Cardiológicos Latinoamérica. Instituto Cardiovascular de Rosario; Argentinaapplication/pdfinfo:eu-repo/semantics/openAccesshttp://creativecommons.org/licences/by-nc-nd/3.0/deed.es_ARCoranivirusCOVID-19Colchicinainfo:eu-repo/semantics/article